Drug Enforcement D-0542-2024

Failed Impurities/Degradation Specifications.

Status

Ongoing

Classification

Class III

Report Date

June 12, 2024

Termination Date

—

Product Information

Product description
Estradiol Transdermal System, USP (Twice-Weekly) 0.0375mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1192-8
Product quantity
21,360 units
Reason for recall
Failed Impurities/Degradation Specifications.
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide within the United States

Location & Firm

Recalling firm
Zydus Pharmaceuticals (USA) Inc
Address
73 Route 31 N, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0542-2024
Event ID
94649
Recall initiation date
May 16, 2024
Center classification date
June 6, 2024
Code info
Lot #: M310493, Exp. Date 01/2025; M308397, Exp. Date 11/2024; M305337, Exp. Date 10/2024; M400155, Exp. Date 06/2025; M314660, Exp. Date 05/2025
More code info
—